
APOE4 STATUS AND COGNITIVE FUNCTION
IN MIDDLE-AGED AND ELDERLY PEOPLE Pavel N.A.1, Paun M.R.2, Matei P.V.1,2, Dutu I.1, Tudose C.1,2 *Corresponding Author: Valentin P. Matei, Associate Proffesor, MD, PhD. 2nd Ward of “Prof. Dr. Alexandru
Obregia” Hospital, Berceni Street no 10, Bucharest, Romania. E-mail: valipmatei@yahoo.com page: 6
|
REFERENCES
1. J. Kim, J. M. Basak, and D. M. Holtzman, “The Role
of Apolipoprotein E in Alzheimer’s Disease,” Neuron.
2009; 63(3): 287–303,
2. O. MC, M. SE, Z. G, N. AC, and M. CE, “APOE
genotype and cognition in healthy individuals at risk
of Alzheimer’s disease: A review,” Cortex. 2018; 104:
103–123.
3. G. Jun et al., “Comprehensive Search for Alzheimer
Disease Susceptibility Loci in the APOE Region,”
Arch Neurol. 2012; 69(10): 1270–1279.
4. L. A. Farrer et al., “Effects of Age, Sex, and Ethnicity
on the Association Between Apolipoprotein E
Genotype and Alzheimer Disease: A Meta-analysis,”
JAMA. 1997; 278(16): 1349–1356.
5. S. M. Laws, E. Hone, S. Gandy, and R. N. Martins,
“Expanding the association between the APOE gene
and the risk of Alzheimer’s disease: possible roles
for APOE promoter polymorphisms and alterations
in APOE transcription,” J. Neurochem. 2003; 84(6):
1215–1236.
6. S. Emrani, H. A. Arain, C. DeMarshall, and T. Nuriel,
“APOE4 is associated with cognitive and pathological
heterogeneity in patients with Alzheimer’s disease:
a systematic review,” Alzheimers. Res. Ther.
2020; 12(1): 141.
7. R. Cacciaglia et al., “Effects of APOE-ε4 allele load
on brain morphology in a cohort of middle-aged
healthy individuals with enriched genetic risk for
Alzheimer’s disease,” Alzheimer’s Dement. 2018;
14(7): 902–912.
8. K. Chen et al., “Correlations between FDG PET
glucose uptake-MRI gray matter volume scores and
apolipoprotein E ε4 gene dose in cognitively normal
adults: a cross-validation study using voxel-based
multi-modal partial least squares,” Neuroimage.
2012; 60(4): 2316.
9. A. Montagne et al., “APOE4 leads to blood–brain
barrier dysfunction predicting cognitive decline,”
Nature. 2020; 581(7806): 71–76.
10. S. Moreno-Grau et al., “Exploring APOE genotype
effects on AD risk and β-amyloid burden in
individuals with subjective cognitive decline: The
FACEHBI study baseline results,” 2017.
11. World Medical Association, “Declaration of Helsinki,
Ethical Principles for Scientific Requirements and
Research Protocols,” World Med. Assoc. 2013; 1964:
29–32.
12. Diagnostic and statistical manual of mental disorders
: DSM-IV. Fourth edition. Washington, DC :
American Psychiatric Association, [1994] ©1994.
13. M. F. Folstein, S. E. Folstein, and P. R. McHugh,
“‘Mini-mental state’. A practical method for grading
the cognitive state of patients for the clinician,” J.
Psychiatr. Res. 1975; 12(3): 189–198.
14. E. Strauss, E. M. S. Sherman, and O. Spreen, A compendium
of neuropsychological tests: Administration,
norms, and commentary, 3rd ed. New York, NY, US:
Oxford University Press, 2006.
15. A. Rey, “L’examen psychologique dans les cas
d’encéphalopathie traumatique. (Les problems.). [The
psychological examination in cases of traumatic encepholopathy.
Problems.],” Arch. Psychol. (Geneve).
1941; 28: 215–285.
16. Z. Shao, E. Janse, K. Visser, and A. S. Meyer, “What
do verbal fluency tasks measure? Predictors of verbal
fluency performance in older adults,” Front. Psychol.
2014; 5: 1–10.
17. M. D. Lezak, D. B. Howieson, D. W. Loring, and J.
S. Fischer, Neuropsychological assessment. Oxford
University Press, USA, 2004.
18. L. M. Nichols et al., “Interactive Effect of Apolipoprotein
E Genotype and Age on Hippocampal Activation
During Memory Processing in Healthy Adults,”
Arch. Gen. Psychiatry. 2012; 69(8): 804–813.
19. G. A. Rodriguez, M. P. Burns, E. J. Weeber, and G.
W. Rebeck, “Young APOE4 targeted replacement
mice exhibit poor spatial learning and memory, with
reduced dendritic spine density in the medial entorhinal
cortex,” Learn. Mem. 2013; 20(5): 256–266.
20. T. Iachini, A. Iavarone, V. P. Senese, F. Ruotolo,
and G. Ruggiero, “Visuospatial Memory in Healthy
Elderly, AD and MCI: A Review,” Curr. Aging Sci.
2009; 2: 43–59.
21. R. J. Piers, Y. Liu, T. F. A. Ang, Q. Tao, R. Au, and
W. Q. Qiu, “Association Between Elevated Depressive
Symptoms and Cognitive Function Moderated
by APOE4 Status: Framingham Offspring Study,” J.
Alzheimer’s Dis. 2021; 80(3): 1269–1279.
22. F. Mashayekhi, S. Sadigh-Eteghad, A. Naseri, M.
Asadi, N. A. Garravnd, and M. Talebi, “ApoE4-positive
multiple sclerosis patients are more likely to
have cognitive impairment: a cross-sectional study,”
Neurol. Sci. 2021. 2021; 1–8.
23. I. Reinvang, T. Espeseth, and L. T. Westlye, “APOErelated
biomarker profiles in non-pathological aging
and early phases of Alzheimer’s disease,” Neurosci.
Biobehav. Rev. 2013; 37: 1322–1335.
|
|
|
|



 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|